Atıf İçin Kopyala
GÜN E., ÖZDEMİR H., Celik D. B., BOTAN E., KENDİRLİ T.
TURKISH JOURNAL OF PEDIATRICS, cilt.64, sa.1, ss.138-141, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
64
Sayı:
1
-
Basım Tarihi:
2022
-
Doi Numarası:
10.24953/turkjped.2020.1668
-
Dergi Adı:
TURKISH JOURNAL OF PEDIATRICS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.138-141
-
Anahtar Kelimeler:
Saccharomyces cerevisiae, sepsis, pediatric intensive care, probiotic, fungemia, PROBIOTIC TREATMENT, INFECTION, PATIENT
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background. Saccharomyces cerevisiae is one of the microorganisms commonly used as a probiotic. Although it is primarily known as non-pathogenic, it may cause fungemia, particularly in immunocompromised patients or children with a history of long-term hospital stay.